As of 2024-12-14, the Intrinsic Value of Akero Therapeutics Inc (AKRO) is
-16.99 USD. This AKRO valuation is based on the model Peter Lynch Fair Value.
With the current market price of 28.89 USD, the upside of Akero Therapeutics Inc is
-158.82%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-16.99 USD
Intrinsic Value
AKRO Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-16.99 - -16.99 |
-16.99 |
-158.82% |
| P/E |
(93.67) - (103.59) |
(91.42) |
-416.4% |
| DDM - Stable |
(26.92) - (104.84) |
(65.88) |
-328.0% |
| DDM - Multi |
(16.00) - (49.67) |
(24.35) |
-184.3% |
AKRO Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
2,016.52 |
| Beta |
1.46 |
| Outstanding shares (mil) |
69.80 |
| Enterprise Value (mil) |
1,735.58 |
| Market risk premium |
4.60% |
| Cost of Equity |
9.88% |
| Cost of Debt |
5.00% |
| WACC |
9.81% |